BELLUS Health Inc. (BLU)

14.570
-0.020(-0.14%)
Pre Market
14.530
-0.040(-0.27%)
- Real-time Data
  • Volume:
    2,232,052
  • Day's Range:
    14.570 - 14.600
  • 52 wk Range:
    6.380 - 14.670

BLU Overview

Prev. Close
14.59
Day's Range
14.57-14.6
Revenue
15K
Open
14.58
52 wk Range
6.38-14.67
EPS
-0.721
Volume
2,232,052
Market Cap
1.85B
Dividend (Yield)
N/A
(N/A)
Average Volume (3m)
4,662,554
P/E Ratio
-20.23
Beta
-0.328
1-Year Change
62.79%
Shares Outstanding
126,812,170
Next Earnings Date
08 Aug 2023
What is your sentiment on BELLUS Health Inc.?
or
Market is currently closed. Voting is open during market hours.

BELLUS Health Inc. Company Profile

BELLUS Health Inc. Company Profile

BELLUS Health Inc. is a clinical-stage biopharmaceutical company developing therapeutics for the treatment of refractory chronic cough (RCC) and other cough hypersensitivity indications. The Company's lead product candidate, BLU-5937, which is a selective, small molecule antagonist of the P2X3 receptor, as an oral therapy to reduce cough frequency in RCC patients. The Company has completed the BLUEPRINT clinical trial, a Phase II trial evaluating BLU-5937 in patients with chronic pruritus associated with AD. The Company is focused on initiating Phase III program. The Company is exploring the use of BLU-5937 in other patient populations experiencing cough hypersensitivity as well as other P2X3-related hypersensitization conditions.

Read More

Analyst Price Target

Average20.496 (+5.215% Upside)
High24.000
Low18.000
Price19.480
No. of Analysts4
Strong Sell
Sell
Neutral
Buy
Strong Buy
Buy
Analysts Consensus

Technical Summary

Type
5 Min
15 Min
Hourly
Daily
Monthly
Moving AveragesStrong SellStrong SellSellBuyStrong Buy
Technical IndicatorsSellSellStrong SellBuyStrong Buy
SummaryStrong SellStrong SellStrong SellBuyStrong Buy